312 related articles for article (PubMed ID: 21371020)
1. The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway.
McDaniel SS; Rensing NR; Thio LL; Yamada KA; Wong M
Epilepsia; 2011 Mar; 52(3):e7-11. PubMed ID: 21371020
[TBL] [Abstract][Full Text] [Related]
2. The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy.
Zeng LH; Rensing NR; Wong M
J Neurosci; 2009 May; 29(21):6964-72. PubMed ID: 19474323
[TBL] [Abstract][Full Text] [Related]
3. Regulation of cell death and epileptogenesis by the mammalian target of rapamycin (mTOR): a double-edged sword?
Zeng LH; McDaniel S; Rensing NR; Wong M
Cell Cycle; 2010 Jun; 9(12):2281-5. PubMed ID: 20603607
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of (immuno)proteasome subunits during epileptogenesis is attenuated by inhibition of the mammalian target of rapamycin pathway.
Broekaart DWM; van Scheppingen J; Geijtenbeek KW; Zuidberg MRJ; Anink JJ; Baayen JC; Mühlebner A; Aronica E; Gorter JA; van Vliet EA
Epilepsia; 2017 Aug; 58(8):1462-1472. PubMed ID: 28643873
[TBL] [Abstract][Full Text] [Related]
5. [Effect of ketogenic diet on hippocampus synaptic reorganization and GluR5 expression in kainic acid induced rat model of epilepsy].
Xu XP; Sun RP; Jin RF
Zhonghua Er Ke Za Zhi; 2006 Feb; 44(2):100-4. PubMed ID: 16624024
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the mammalian target of rapamycin signaling pathway suppresses dentate granule cell axon sprouting in a rodent model of temporal lobe epilepsy.
Buckmaster PS; Ingram EA; Wen X
J Neurosci; 2009 Jun; 29(25):8259-69. PubMed ID: 19553465
[TBL] [Abstract][Full Text] [Related]
7. Role of the mTOR signaling pathway in epilepsy.
Meng XF; Yu JT; Song JH; Chi S; Tan L
J Neurol Sci; 2013 Sep; 332(1-2):4-15. PubMed ID: 23773767
[TBL] [Abstract][Full Text] [Related]
8. Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies.
Wong M
Epilepsia; 2010 Jan; 51(1):27-36. PubMed ID: 19817806
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis.
McDaniel SS; Wong M
Neurosci Lett; 2011 Jun; 497(3):231-9. PubMed ID: 21354266
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of the activated mammalian target of rapamycin pathway might be associated with renal function reserve by a low-protein diet in the rat remnant kidney model.
Ohkawa S; Yanagida M; Uchikawa T; Yoshida T; Ikegaya N; Kumagai H
Nutr Res; 2013 Sep; 33(9):761-71. PubMed ID: 24034576
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin reveals an mTOR-independent repression of Kv1.1 expression during epileptogenesis.
Sosanya NM; Brager DH; Wolfe S; Niere F; Raab-Graham KF
Neurobiol Dis; 2015 Jan; 73():96-105. PubMed ID: 25270294
[TBL] [Abstract][Full Text] [Related]
12. Impact of rapamycin on status epilepticus induced hippocampal pathology and weight gain.
Hester MS; Hosford BE; Santos VR; Singh SP; Rolle IJ; LaSarge CL; Liska JP; Garcia-Cairasco N; Danzer SC
Exp Neurol; 2016 Jun; 280():1-12. PubMed ID: 26995324
[TBL] [Abstract][Full Text] [Related]
13. mTOR-dependent alterations of Kv1.1 subunit expression in the neuronal subset-specific Pten knockout mouse model of cortical dysplasia with epilepsy.
Nguyen LH; Anderson AE
Sci Rep; 2018 Feb; 8(1):3568. PubMed ID: 29476105
[TBL] [Abstract][Full Text] [Related]
14. A Warburg-like metabolic program coordinates Wnt, AMPK, and mTOR signaling pathways in epileptogenesis.
Alqurashi RS; Yee AS; Malone T; Alrubiaan S; Tam MW; Wang K; Nandedwalla RR; Field W; Alkhelb D; Given KS; Siddiqui R; Baleja JD; Paulson KE; Yee AS
PLoS One; 2021; 16(8):e0252282. PubMed ID: 34358226
[TBL] [Abstract][Full Text] [Related]
15. Curcumin reduces development of seizurelike events in the hippocampal-entorhinal cortex slice culture model for epileptogenesis.
Drion CM; Kooijman L; Aronica E; van Vliet EA; Wadman WJ; Chameau P; Gorter JA
Epilepsia; 2019 Apr; 60(4):605-614. PubMed ID: 30747999
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood-brain barrier leakage but not microglia activation.
van Vliet EA; Forte G; Holtman L; den Burger JC; Sinjewel A; de Vries HE; Aronica E; Gorter JA
Epilepsia; 2012 Jul; 53(7):1254-63. PubMed ID: 22612226
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor-γ agonist inhibits the mammalian target of rapamycin signaling pathway and has a protective effect in a rat model of status epilepticus.
San YZ; Liu Y; Zhang Y; Shi PP; Zhu YL
Mol Med Rep; 2015 Aug; 12(2):1877-83. PubMed ID: 25891824
[TBL] [Abstract][Full Text] [Related]
18. Mapping the spatio-temporal pattern of the mammalian target of rapamycin (mTOR) activation in temporal lobe epilepsy.
Sha LZ; Xing XL; Zhang D; Yao Y; Dou WC; Jin LR; Wu LW; Xu Q
PLoS One; 2012; 7(6):e39152. PubMed ID: 22761730
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy.
Huang X; Zhang H; Yang J; Wu J; McMahon J; Lin Y; Cao Z; Gruenthal M; Huang Y
Neurobiol Dis; 2010 Oct; 40(1):193-9. PubMed ID: 20566381
[TBL] [Abstract][Full Text] [Related]
20. Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target.
Galanopoulou AS; Gorter JA; Cepeda C
Epilepsia; 2012 Jul; 53(7):1119-30. PubMed ID: 22578218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
